Asthma Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies – GlaxoSmithKline, 4D Pharma plc, AstraZeneca, Suzhou Connect Biopharma

December 07 04:00 2022
Asthma Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies - GlaxoSmithKline, 4D Pharma plc, AstraZeneca, Suzhou Connect Biopharma
The Asthma market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Asthma pipeline products will significantly revolutionize the Asthma market dynamics.

DelveInsight’s “Asthma Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Asthma, historical and forecasted epidemiology as well as the Asthma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


The Asthma market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 


To Know in detail about the Asthma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Asthma Market Insights


Asthma Overview

According to the American Academy of Allergy, Asthma, & Immunology (AAAAI), asthma is a chronic disease affecting the airways in the lungs. These airways, or bronchial tubes, allow air to come in and out of the lungs. Asthma is a heterogeneous disease characterized by episodes of airways narrowing or hyper responsiveness, obstruction, inflammation and mucous production. Asthma clinically presents as wheezing, coughing, chest tightness and shortness of breath. Different inflammatory pathways drive the airway inflammation and hyper responsiveness associated with asthma.


Some of the key facts of the Asthma Market Report: 

  • The Asthma market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • According to the WHO, asthma is a major non-communicable disease (NCD), affecting both children and adults, and is the most common chronic disease among children
  • According to Asthma + Lung UK, 5.4 million people in the UK are currently receiving treatment for asthma: 1.1 million children (1 in 11) and 4.3 million adults (1 in 12)
  • In February 2022, Honeywell announced a commercial partnership with AstraZeneca to develop and bring to market next-generation respiratory inhalers that use near-zero global warming potential (GWP) propellants to treat asthma and chronic obstructive pulmonary disease (COPD)
  • Key Asthma Companies: GlaxoSmithKline, 4D Pharma plc, AstraZeneca, Suzhou Connect Biopharmaceuticals, and others
  • Key Asthma Therapies: GSK3511294 (depemokimab), MRx-4DP0004, AZD5718, CBP-201, and others
  • The Asthma epidemiology based on gender analyzed that as adults, women have an increased prevalence and severity of asthma


Get a Free sample for the Asthma Market Report-


Key benefits of the Asthma Market report:

  1. Asthma market report covers a descriptive overview and comprehensive insight of the Asthma Epidemiology and Asthma market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Asthma market report provides insights on the current and emerging therapies.
  3. Asthma market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Asthma market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Asthma market.


Download the report to understand which factors are driving Asthma epidemiology trends @ Asthma Epidemiological Insights 


Asthma Market  

The dynamics of the Asthma market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.  


Asthma Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.


Asthma Epidemiology Segmentation:

The Asthma market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Asthma
  • Prevalent Cases of Asthma by severity
  • Gender-specific Prevalence of Asthma
  • Diagnosed Cases of Episodic and Chronic Asthma


Asthma Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Asthma market or expected to get launched during the study period. The analysis covers Asthma market uptake by drugs, patient uptake by therapies, and sales of each drug.  

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Asthma Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.


Discover more about therapies set to grab major Asthma market share @ Asthma market forecast 


Asthma Therapies and Key Companies

  • GSK3511294 (depemokimab): GlaxoSmithKline
  • MRx-4DP0004: 4D Pharma plc
  • AZD5718: AstraZeneca
  • CBP-201: Suzhou Connect Biopharmaceuticals


Scope of the Asthma Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Asthma Companies: GlaxoSmithKline, 4D Pharma plc, AstraZeneca, Suzhou Connect Biopharmaceuticals, and others
  • Key Asthma Therapies: GSK3511294 (depemokimab), MRx-4DP0004, AZD5718, CBP-201, and others
  • Asthma Therapeutic Assessment: Asthma current marketed and Asthma emerging therapies
  • Asthma Market Dynamics: Asthma market drivers and Asthma market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Asthma Unmet Needs, KOL’s views, Analyst’s views, Asthma Market Access and Reimbursement 


Table of Contents 

1. Asthma Market Report Introduction

2. Executive Summary for Asthma

3. SWOT analysis of Asthma

4. Asthma Patient Share (%) Overview at a Glance

5. Asthma Market Overview at a Glance

6. Asthma Disease Background and Overview

7. Asthma Epidemiology and Patient Population

8. Country-Specific Patient Population of Asthma 

9. Asthma Current Treatment and Medical Practices

10. Asthma Unmet Needs

11. Asthma Emerging Therapies

12. Asthma Market Outlook

13. Country-Wise Asthma Market Analysis (2019–2032)

14. Asthma Market Access and Reimbursement of Therapies

15. Asthma Market Drivers

16. Asthma Market Barriers

17.  Asthma Appendix

18. Asthma Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight


To know more about Asthma treatment, visit @ Asthma Medications

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States